Skip to main content
. 2020 Nov 18;8(11):515. doi: 10.3390/biomedicines8110515

Table 2.

Changes in clinical variables (mean ± SD) over the 6-month experimental period (gingival crevicular fluid (GCF) sampling sites).

Variables Group Moderate Pocket Sites
(4–5 mm)
Deep Pocket Sites
(≥6 mm)
Baseline 6 Months Baseline 6 Months
PI Stage B 85.0 ± 23.5 10.0 ± 20.5 *** 92.5 ± 18.3 25.0 ± 30.3 ***
Stage C 77.5 ± 25.5 15.0 ± 28.6 *** 95.0 ± 15.4 20.0 ± 29.9 ***
Difference between groups NS NS NS NS
GI Stage B 2.0 ± 0.5 0.6 ± 0.5 *** 2.6 ± 0.5 0.9 ± 0.8 ***
Stage C 1.8 ± 0.4 0.4 ± 0.6 *** 2.4 ± 0.4 0.8 ± 0.7 ***
Difference between groups NS NS NS NS
PD (mm) Stage B 4.7 ± 0.5 3.0 ± 1.0 *** 8.2 ± 1.4 4.5 ± 0.9 ***
Stage C 4.8 ± 0.4 3.2 ± 0.6 *** 8.9 ± 1.7 4.9 ± 1.0 ***
Difference between groups NS NS NS NS
CAL (mm) Stage B 5.8 ± 1.4 4.5 ± 1.8 ** 9.3 ± 2.1 6.4 ± 2.1 **
Stage C 5.3 ± 0.7 4.1 ± 1.1 *** 9.6 ± 1.9 6.6 ± 1.4 ***
Difference between groups NS NS NS NS
GCF (µL) Stage B 0.56 ± 0.36 0.22 ± 0.15 ** 1.09 ± 0.25 § 0.45 ± 0.21 ***
Stage C 0.59 ± 0.39 0.27 ± 0.20 * 1.13 ± 0.33 § 0.54 ± 0.31 **
Difference between groups NS NS NS NS

SD: standard deviation; GCF: gingival crevicular fluid; PI: presence of plaque; GI: gingival index; PD: probing depth; CAL: clinical attachment level; NS: difference between groups is not statistically significant (p > 0.05); * p < 0.05 versus baseline; ** p < 0.01 versus baseline. *** p < 0.001 versus baseline; p < 0.01 versus moderate pocket sites; § p < 0.001 versus moderate pocket sites.